Detalles de la búsqueda
1.
A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer.
Cancer Immunol Immunother
; 68(5): 799-812, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30770959
2.
Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial.
Lancet
; 390(10101): 1511-1520, 2017 Sep 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-28754494
3.
Immunologic response to the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors.
Cancer Immunol Immunother
; 63(4): 381-94, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24487961
4.
Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer.
BMC Cancer
; 14: 748, 2014 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-25288198
5.
T-cell activation by treatment of cancer patients with EMD 521873 (Selectikine), an IL-2/anti-DNA fusion protein.
J Transl Med
; 11: 5, 2013 Jan 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-23294527
6.
Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma.
Clin Cancer Res
; 28(12): 2555-2566, 2022 06 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35421231
7.
RNA-based adjuvant CV8102 enhances the immunogenicity of a licensed rabies vaccine in a first-in-human trial.
Vaccine
; 37(13): 1819-1826, 2019 03 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-30797640
8.
Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer.
J Immunother Cancer
; 7(1): 38, 2019 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30736848
9.
Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapy.
Oncoimmunology
; 5(12): e1249560, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-28123889
10.
Short Peptide Vaccine Induces CD4+ T Helper Cells in Patients with Different Solid Cancers.
Cancer Immunol Res
; 4(1): 18-25, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26563311
11.
Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study.
J Immunother Cancer
; 3: 26, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26082837
12.
A phase I dose-escalation study of the immunocytokine EMD 521873 (Selectikine) in patients with advanced solid tumours.
Eur J Cancer
; 49(1): 35-44, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22918078
13.
NSCLC - immunogenic after all?
J Thorac Dis
; 3(2): 79-81, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22263067
14.
Irinotecan and capecitabine as second-line treatment after failure for first-line infusional 24-h 5-fluorouracil/folinic acid in advanced colorectal cancer: a phase II study.
Anticancer Drugs
; 16(1): 39-45, 2005 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-15613902
Resultados
1 -
14
de 14
1
Próxima >
>>